We also investigated the relationship of the Nrf2/HO-1 pathway with the Ca2+/CaMKII/CREB pathway; ML385, an Nrf2 inhibitor, was used to treat HF mice before NBP administration. Here, NFE2L2 is linked to hydrops fetalis.